Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

What is the Role of Transoral Thyroidectomy?

Chang BA, Asarkar AA, Nathan CO.

Laryngoscope. 2020 Feb 21. doi: 10.1002/lary.28578. [Epub ahead of print] No abstract available.

PMID:
32083722
2.

What is the oncologic safety of using the submental flap to reconstruct oral cavity cancer defects?

Chang BA, Asarkar AA, Nathan CO.

Laryngoscope. 2019 Nov;129(11):2443-2444. doi: 10.1002/lary.28193. Epub 2019 Aug 19. Review. No abstract available.

PMID:
31424567
3.

Gender disparities are present in academic rank and leadership positions despite overall equivalence in research productivity indices among senior members of American Head and Neck Society (AHNS) Fellowship Faculty.

Garstka ME, Randolph GW, Haddad AB, Nathan CO, Ibraheem K, Farag M, Deot N, Adib H, Hoof M, French K, Killackey MT, Kandil E.

Head Neck. 2019 Nov;41(11):3818-3825. doi: 10.1002/hed.25913. Epub 2019 Aug 16.

PMID:
31418942
4.

Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.

Khandelwal AR, Kent B, Hillary S, Alam MM, Ma X, Gu X, DiGiovanni J, Nathan CO.

Mol Carcinog. 2019 Oct;58(10):1715-1725. doi: 10.1002/mc.23012. Epub 2019 Jun 29.

PMID:
31254372
5.

Point/Counterpoint: Do We De-escalate Treatment of HPV-Associated Oropharynx Cancer Now? And How?

Wirth LJ, Burtness B, Nathan CO, Grégoire V, Richmon J.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:364-372. doi: 10.1200/EDBK_238315. Epub 2019 May 17. Review.

6.

Is primary radiotherapy an acceptable treatment modality for verrucous carcinoma of the larynx?

Chang BA, Katz S, Kompelli AR, Nathan CO.

Laryngoscope. 2019 Sep;129(9):1964-1965. doi: 10.1002/lary.27985. Epub 2019 Apr 5. Review. No abstract available.

PMID:
30950508
7.

Perioperative Management of Total Laryngectomy Patients: A Survey of American Head and Neck Society Surgeons.

Ahmed OH, Roden DF, Ahmed YC, Wang B, Nathan CO, Myssiorek D.

Ann Otol Rhinol Laryngol. 2019 Jun;128(6):534-540. doi: 10.1177/0003489419830118. Epub 2019 Feb 13.

PMID:
30758235
8.

Local and systemic Curcumin C3 complex inhibits 4NQO-induced oral tumorigenesis via modulating FGF-2/FGFR-2 activation.

Khandelwal AR, Moore-Medlin T, Ekshyyan O, Gu X, Abreo F, Nathan CO.

Am J Cancer Res. 2018 Dec 1;8(12):2538-2547. eCollection 2018.

9.

Curcumin gum formulation for prevention of oral cavity head and neck squamous cell carcinoma.

Boven L, Holmes SP, Latimer B, McMartin K, Ma X, Moore-Medlin T, Khandelwal AR, McLarty J, Nathan CO.

Laryngoscope. 2019 Jul;129(7):1597-1603. doi: 10.1002/lary.27542. Epub 2018 Nov 13.

PMID:
30421467
10.

Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.

Guidry JT, Myers JE, Bienkowska-Haba M, Songock WK, Ma X, Shi M, Nathan CO, Bodily JM, Sapp MJ, Scott RS.

J Virol. 2019 Jan 4;93(2). pii: e01216-18. doi: 10.1128/JVI.01216-18. Print 2019 Jan 15.

11.

To kiss or not to kiss in the era of the human papillomavirus-associated head and neck cancer "epidemic"?

Rettig EM, Fakhry C, Nathan CO.

Laryngoscope. 2019 Jan;129(1):4-5. doi: 10.1002/lary.27277. Epub 2018 Sep 8. Review. No abstract available.

PMID:
30194848
12.

When Should Parotidectomy and a Neck Dissection Be Performed in Cutaneous SCC of the Head and Neck?

Asarkar A, Bundrick P, Nathan CO.

Laryngoscope. 2019 Mar;129(3):535-536. doi: 10.1002/lary.27274. Epub 2018 Sep 8. Review. No abstract available.

PMID:
30194846
13.

A pilot study of Merkel cell polyomavirus in squamous cell carcinoma of the tongue.

Hamiter M, Asarkar A, Rogers D, Moore-Medlin T, McClure G, Ma X, Vanchiere J, Nathan CO.

Oral Oncol. 2017 Nov;74:111-114. doi: 10.1016/j.oraloncology.2017.09.021. Epub 2017 Oct 4. No abstract available.

PMID:
29103738
14.

Survival outcomes based on systemic agent used concurrently with radiation in human-papillomavirus associated oropharyngeal cancer.

Mehta V, Moore-Medlin T, Flores JM, Ma X, Ekshyyan O, Nathan CO.

Oncotarget. 2017 Aug 10;8(41):70907-70915. doi: 10.18632/oncotarget.20197. eCollection 2017 Sep 19.

15.

In response to Does mutational analysis influence the management of differentiated thyroid cancers?

Nathan CO, Asarkar A, Shaha M, Shaha A.

Laryngoscope. 2018 Feb;128(2):E85. doi: 10.1002/lary.26842. Epub 2017 Aug 22. No abstract available.

PMID:
28833249
16.

Does mutational analysis influence the management of differentiated thyroid cancers?

Asarkar A, Shaha M, Shaha A, Nathan CO.

Laryngoscope. 2018 Jan;128(1):1-2. doi: 10.1002/lary.26650. Epub 2017 May 17. Review. No abstract available.

PMID:
28514497
17.

Incidence of contralateral-bilateral nodes in the human papillomavirus era.

Tritter AG, Mehta V, Samuelson M, deGravelle G, Ma X, Medlin-Moore T, Takalkar A, Caldito G, Nathan CO.

Laryngoscope. 2017 Jun;127(6):1328-1333. doi: 10.1002/lary.26439. Epub 2016 Dec 1.

PMID:
27905120
18.

Rapamycin targets Interleukin 6 (IL-6) expression and suppresses endothelial cell invasion stimulated by tumor cells.

Ekshyyan O, Khandelwal AR, Rong X, Moore-Medlin T, Ma X, Alexander JS, Nathan CO.

Am J Transl Res. 2016 Nov 15;8(11):4822-4830. eCollection 2016.

19.

Intermittently symptomatic tracheal diverticulum: a case of a rare clinical phenomenon.

Smelley CL, Bowen R, Nathan CO.

Ear Nose Throat J. 2011 Sep;90(9):E10-2.

PMID:
21938686
20.

Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.

Sunavala-Dossabhoy G, Palaniyandi S, Clark C, Nathan CO, Abreo FW, Caldito G.

Laryngoscope. 2011 Oct;121(10):2136-41. doi: 10.1002/lary.22144. Epub 2011 Sep 6.

PMID:
21898433
21.

Utility of panendoscopy for the detection of unknown primary head and neck cancer in patients with a negative PET/CT scan.

Pattani KM, Goodier M, Lilien D, Kupferman T, Caldito G, Nathan CO.

Ear Nose Throat J. 2011 Aug;90(8):E16-20.

PMID:
21853427
22.

Efficacy and comparative effectiveness of sirolimus as an anticancer drug.

Hu M, Ekshyyan O, Herman Ferdinandez L, Rong X, Caldito G, Nathan CO.

Laryngoscope. 2011 May;121(5):978-82. doi: 10.1002/lary.21724.

23.

Intraoperative parathyroid hormone assay: a necessary tool for multiglandular disease.

Gill MT, Dean M, Karr J, Aultman DF, Nathan CO.

Otolaryngol Head Neck Surg. 2011 May;144(5):691-7. doi: 10.1177/0194599811398597.

PMID:
21493339
24.

Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma.

Compton AM, Moore-Medlin T, Herman-Ferdinandez L, Clark C, Caldito GC, Wang XI, Thomas J, Abreo FW, Nathan CO.

Otolaryngol Head Neck Surg. 2011 Jul;145(1):51-7. doi: 10.1177/0194599811400385.

PMID:
21493313
25.

Curcumin inhibits skin squamous cell carcinoma tumor growth in vivo.

Phillips JM, Clark C, Herman-Ferdinandez L, Moore-Medlin T, Rong X, Gill JR, Clifford JL, Abreo F, Nathan CO.

Otolaryngol Head Neck Surg. 2011 Jul;145(1):58-63. doi: 10.1177/0194599811400711.

PMID:
21493306
26.

Timing of esophageal dilation for dysphagia in head and neck cancer patients receiving radiation therapy.

Cho AH, Caldito G, Nathan CO.

Laryngoscope. 2010;120 Suppl 4:S145. doi: 10.1002/lary.21609.

PMID:
21225743
27.

Curcumin inhibits carcinogen and nicotine-induced Mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma.

Clark CA, McEachern MD, Shah SH, Rong Y, Rong X, Smelley CL, Caldito GC, Abreo FW, Nathan CO.

Cancer Prev Res (Phila). 2010 Dec;3(12):1586-95. doi: 10.1158/1940-6207.CAPR-09-0244. Epub 2010 Sep 17.

28.

Tracheal non-Hodgkin's lymphoma masquerading as benign granulation tissue: a report of two cases.

Gill MT, Cotelingam JD, Lowery-Nordberg M, Nathan CO.

Ann Otol Rhinol Laryngol. 2010 Jul;119(7):431-5.

PMID:
20734962
29.

A unique case of a sublingual-space schwannoma arising from the mylohyoid nerve.

Pattani KM, Dowden K, Nathan CO.

Ear Nose Throat J. 2010 Jul;89(7):E31-3.

PMID:
20628977
30.

Teasing out the best molecular marker in the AKT/mTOR pathway in head and neck squamous cell cancer patients.

Clark C, Shah S, Herman-Ferdinandez L, Ekshyyan O, Abreo F, Rong X, McLarty J, Lurie A, Milligan EJ, Nathan CO.

Laryngoscope. 2010 Jun;120(6):1159-65. doi: 10.1002/lary.20917.

31.

Electrical stimulation of post-irradiated head and neck squamous cell carcinoma to improve xerostomia.

Pattani KM, McDuffie CM, Morgan M, Armstrong C, Nathan CO.

J La State Med Soc. 2010 Jan-Feb;162(1):21-5.

PMID:
20336953
32.

Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma.

Ekshyyan O, Mills GM, Lian T, Amirghahari N, Rong X, Lowery-Nordberg M, Abreo F, Veillon DM, Caldito G, Speicher L, Glass J, Nathan CO.

Head Neck. 2010 Dec;32(12):1619-28. doi: 10.1002/hed.21374.

PMID:
20222045
33.

Radiologic findings after successful chemoradiation for nasopharyngeal cancer with skull base erosion.

Ampil F, Sangster G, Mills G, Nathan CO, Lian T, Hall A.

Ear Nose Throat J. 2010 Jan;89(1):38-41. Erratum in: Ear Nose Throat J. 2010 Oct;89(10):486. Nathan, Cherie Ann [corrected to Nathan, Cherie-Ann O].

PMID:
20155699
34.

N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?

Cho AH, Shah S, Ampil F, Bhartur S, Nathan CO.

Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1112-8. doi: 10.1001/archoto.2009.148.

PMID:
19917924
35.

Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma.

Ekshyyan O, Rong Y, Rong X, Pattani KM, Abreo F, Caldito G, Chang JK, Ampil F, Glass J, Nathan CO.

Mol Cancer Ther. 2009 Aug;8(8):2255-65. doi: 10.1158/1535-7163.MCT-08-1184. Epub 2009 Jul 22.

36.

Reflux as a cause of tracheoesophageal puncture failure.

Pattani KM, Morgan M, Nathan CO.

Laryngoscope. 2009 Jan;119(1):121-5. doi: 10.1002/lary.20052.

PMID:
19117290
37.

Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells.

Jiang R, Gu X, Nathan CO, Hutt-Fletcher L.

J Oral Pathol Med. 2008 Nov;37(10):626-33. doi: 10.1111/j.1600-0714.2008.00681.x. Epub 2008 Aug 15.

38.

Pilot randomized phase II study of celecoxib in oral premalignant lesions.

Papadimitrakopoulou VA, William WN Jr, Dannenberg AJ, Lippman SM, Lee JJ, Ondrey FG, Peterson DE, Feng L, Atwell A, El-Naggar AK, Nathan CO, Helman JI, Du B, Yueh B, Boyle JO.

Clin Cancer Res. 2008 Apr 1;14(7):2095-101. doi: 10.1158/1078-0432.CCR-07-4024.

39.

Return of vocal cord movement: an independent predictor of response to nonsurgical management of laryngeal cancers.

Iloabachie K, Nathan CO, Ampil F, Morgan ML, Caldito G.

Laryngoscope. 2007 Nov;117(11):1925-9.

PMID:
17828050
40.

Mammalian target of rapamycin inhibitors as possible adjuvant therapy for microscopic residual disease in head and neck squamous cell cancer.

Nathan CO, Amirghahari N, Rong X, Giordano T, Sibley D, Nordberg M, Glass J, Agarwal A, Caldito G.

Cancer Res. 2007 Mar 1;67(5):2160-8.

41.

Total laryngectomy and T3-T4 laryngeal cancer without other adverse histopathology.

Ampil FL, Nathan CO, Lian TS, Caldito G, Milligan E.

Otolaryngol Head Neck Surg. 2007 Feb;136(2):296-300.

PMID:
17275558
42.

The voice-controlled robotic assist scope holder AESOP for the endoscopic approach to the sella.

Nathan CO, Chakradeo V, Malhotra K, D'Agostino H, Patwardhan R.

Skull Base. 2006 Aug;16(3):123-31.

43.

Squamous cell carcinoma of the oral cavity following breast cancer treatment.

Ye G, Burton GV, Nathan CO, Ampil FL.

South Med J. 2006 Oct;99(10):1150-1. No abstract available.

PMID:
17100048
44.

Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.

Mathis JM, Williams BJ, Sibley DA, Carroll JL, Li J, Odaka Y, Barlow S, Nathan CO, Li BD, DeBenedetti A.

J Gene Med. 2006 Sep;8(9):1105-20.

PMID:
16802401
45.

Predictive factors for posterior triangle metastasis in HNSCC.

McDuffie CM, Amirghahari N, Caldito G, Lian TS, Thompson L, Nathan CO.

Laryngoscope. 2005 Dec;115(12):2114-7.

PMID:
16369153
46.

Anaplastic thyroid cancer and hyperthyroidism.

Kumar V, Blanchon B, Gu X, Fowler M, Scarborough D, Nathan CO, Yaturu S.

Endocr Pathol. 2005 Fall;16(3):245-50.

PMID:
16299408
47.

Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A.

Moody CA, Scott RS, Amirghahari N, Nathan CO, Young LS, Dawson CW, Sixbey JW.

J Virol. 2005 May;79(9):5499-506.

48.

Unilateral vocal cord paralysis causes contralateral false-positive positron emission tomography scans of the larynx.

Lee M, Ramaswamy MR, Lilien DL, Nathan CO.

Ann Otol Rhinol Laryngol. 2005 Mar;114(3):202-6.

PMID:
15825569
49.

Botulinum toxin: helpful adjunct to early resolution of laryngeal granulomas.

Pham J, Yin S, Morgan M, Stucker F, Nathan CO.

J Laryngol Otol. 2004 Oct;118(10):781-5.

PMID:
15550184
50.

Head and neck cancer with simultaneous lung cancer.

Ampil FL, Mills GM, Heldmann M, Nathan CO.

J La State Med Soc. 2004 Jul-Aug;156(4):193-5.

PMID:
15366347

Supplemental Content

Loading ...
Support Center